Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.

GSK’s share price has fallen significantly in the past 12 months, but this could mean it looks a major bargain now, ...

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...

The GSK (GSK.L) share price has fallen considerably since the company’s demerger with its consumer healthcare arm Haleon (HLN.L) in July 2022. However, the stock did surge around 7.5% at the end of ...

The GSK (GSK.L) share price gained 3% in early trading Wednesday (30 April), as the pharmaceuticals giant told us it’s “well positioned to respond to the potential financial impact of sector-specific ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2827.05. The stock has experienced fluctuations ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 numbers. Learn more about GSK stock here.

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand in the U.S. GSK plans to bring five new specialty medicines to market ...